On Invalid Date, 2seventy Bio (NASDAQ: TSVT) reported Q1 2023 earnings per share (EPS) of -$1.08, up 66.25% year over year. Total 2seventy Bio earnings for the quarter were -$47.02 million. In the same quarter last year, 2seventy Bio's earnings per share (EPS) was -$3.20.
As of Q2 2023, 2seventy Bio's earnings has grown year over year. 2seventy Bio's earnings in the past year totalled -$215.46 million.
What was TSVT's revenue last quarter?
On Invalid Date, 2seventy Bio (NASDAQ: TSVT) reported Q1 2023 revenue of $41.62 million up 393.78% year over year. In the same quarter last year, 2seventy Bio's revenue was $8.43 million.
What was TSVT's revenue growth in the past year?
As of Q2 2023, 2seventy Bio's revenue has grown 144.26% year over year. This is 143.56 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 0.69%. 2seventy Bio's revenue in the past year totalled $124.69 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.